PIII vs ASTH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

PIII

42.9
AI Score
VS
ASTH Wins

ASTH

48.7
AI Score

Investment Advisor Scores

PIII

43score
Recommendation
HOLD

ASTH

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PIII ASTH Winner
Forward P/E 0 8.9686 Tie
PEG Ratio 0 0 Tie
Revenue Growth 8.6% 48.5% ASTH
Earnings Growth 0.0% 110.5% ASTH
Tradestie Score 42.9/100 48.7/100 ASTH
Profit Margin -6.6% 1.1% ASTH
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

PIII 1M: -23.9% · 3M: -71.1% ASTH 1M: -16.2% · 3M: -10.1%

Current Technical Phase

PIII

Markdown
Sell / avoid

Price below a falling SMA50 (slope -30.7%), weak momentum, RSI 32

RSI (14): 32.3 · Price: $3.38

ASTH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.8%), weak momentum, RSI 34

RSI (14): 33.7 · Price: $32.18

Fundamentals Snapshot

Metric PIII ASTH
Market Cap — —
Forward P/E -0.2 8.9
Trailing P/E — 31.9
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.0% 0.1%
Operating Margin 0.1% 0.0%
EPS -33.02 1.06
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.